Akeso lung cancer drug shines in trials, boosting hopes in US$20b market
AdvertisementChina’s private sectorBusinessChina Business Akeso lung cancer drug shines in trials, boosting hopes in US$20b market Ivonescimab phase three trials…
CSRC’s crackdown on cross-border trading involves US$32b in Hong Kong assets: Citic
AdvertisementHong Kong stock marketBusinessChina Business CSRC’s crackdown on cross-border trading involves US$32b in Hong Kong assets: Citic The assets involve…
Hong Kong secures US$3.5 billion to fund Northern Metropolis and green projects
AdvertisementBanking & financeBusinessBanking & Finance Hong Kong secures US$3.5 billion to fund Northern Metropolis and green projects Global investors pile…
Baidu chip unit Kunlunxin eyes US$14.7b valuation in Hong Kong IPO: sources
AdvertisementSemiconductorsTechTech Trends ExclusiveBaidu chip unit Kunlunxin eyes US$14.7b valuation in Hong Kong IPO: sources The company is seeking to list…
HSBC profit flat as Middle East provisions offset wealth growth
AdvertisementBanking & financeBusinessBanking & Finance HSBC profit flat as Middle East provisions offset wealth growth HSBC stock slides 5.2 per…